Results 211 to 220 of about 10,726 (293)

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

Arthritis &Rheumatology, EarlyView.
Objective Transition from long‐term denosumab (Dmab) to parathyroid hormone‐analogs or romosozumab (Romo) might expose patients to the risk of the so‐called rebound phenomenon. Adding Romo to Dmab might represent an option in patients experiencing a fracture while on Dmab.
Giovanni Adami, Francesco Pollastri, Angelo Fassio, Filippo Montanari, Anna Piccinelli, Camilla Benini, Emma Pasetto, Carmen Dartizio, Davide Gatti, Maurizio Rossini, Ombretta Viapiana   +10 more
wiley   +1 more source

The THE EFFECT OF ECONOMIC FREEDOMS ON PUBLIC DEBT IN TÜRKİYE

Journal of Process Management and New Technologies
Salim Üre, Çağatay KARAKÖY
doaj   +1 more source

A Right to Constructive Optimization: A Public Interest Approach to Recommender Systems in the Digital Services Act. [PDF]

J Consum Policy (Dordr)
Naudts L, Helberger N, Veale M, Sax M.
europepmc   +1 more source

Poverty and economic freedom : evidence from cross-country data

, 2003
Rana Hasan, M. G. Quibria, Yangseon Kim
openalex   +1 more source

Coverage generosity of novel anti‐rheumatic drugs in Medicare Advantage and stand‐alone Part D plans

Arthritis &Rheumatology, Accepted Article.
Objective To examine coverage of self‐administered disease‐modifying anti‐rheumatic drugs (DMARDs) in Medicare Part D. Methods Using 2022‐2026 Part D formulary data, we assessed coverage of the following DMARD classes that treat relapsed rheumatoid arthritis (RA): tumor necrosis factor (TNF) inhibitors, T‐cell co‐stimulatory modulator, Interleukin‐6 ...
Youngmin Kwon, Robert W. Corty, Stacie B. Dusetzina   +2 more
wiley   +1 more source

Studying the Potential Effects of Artificial Intelligence on Physician Autonomy: Scoping Review. [PDF]

JMIR AI
Grosser J, Düvel J, Hasemann L, Schneider E, Greiner W.   +4 more
europepmc   +1 more source

The lack of legal protections in the United States to prevent commercializing the dead for education and research: Consequences and risks to anatomists

Anatomical Sciences Education, EarlyView.
Abstract A lack of minimum legal standards for body donation programs undermines recent strides by anatomy professionals to promote ethical best practices in the United States (US). In particular, the commercialization of the dead by nontransplant tissue banks poses a risk to the public trust in academic body donation programs.
Laura E. Johnson
wiley   +1 more source

Content analysis of media coverage on smoke-free policy implementation in ten low- and middle-income countries. [PDF]

Tob Induc Dis
Xing E, Kim S, Cohen JE, Tseng TY.
europepmc   +1 more source

Low‐intervention clinical trials in Spain: Do they progress?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza, Mayro J. Cortés Pestana, Kristopher Amaro, Rosa M. Antonijoan, Caridad Pontes   +4 more
wiley   +1 more source

Exploring the nexus between climate finance, rural-urban disparities, and rural brain drain in Somalia: the mediating role of climate resilience. [PDF]

Front Sociol
Nor MI.
europepmc   +1 more source